← Leaderboards
Joanne T Douglas
University Of Alabama At Birmingham
$899,076
Attributed
$899,076
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $232.4K · FY2006–08$250K$187.5K$125K$62.5K$0
'06
'07
'08
Funding mix
By agency
NIH$899,076 · 2
By mechanism
R01$683,826 · 1
R03$215,250 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- David T Curiel$31,690,411
- Selvarangan Ponnazhagan$11,274,357
- Michael J. Passineau$3,229,863
- Richard J. Whitley$15,110,969
- James M Shikany$12,027,044
Others in their field
Top investigators on “Transfection /Expression Vector”
- William W Hauswirth · University Of Florida$14,472,513
- Kenneth G Cornetta · Indiana Univ-Purdue Univ At Indianapolis$10,466,261
- Klaus H. Kaestner · University Of Pennsylvania$8,467,407
- David T Curiel · University Of Alabama At Birmingham$8,321,535
- Timothy A Cross · Florida State University$7,979,166
- John H Wolfe · Children'S Hospital Of Philadelphia$7,103,743
Research focus
Transfection /Expression VectorGene TargetingImmunogeneticsTechnology /Technique DevelopmentOsteoblastsHormone Regulation /Control MechanismGene TherapyHuman TissueOsteocalcinParathyroid HormonesOsteoporosisOsteoclastsBone MetabolismHuman SubjectBiotechnologyCell DeathCell CycleBinding (Molecular Function)Cancer CellBreast Cancer CellBase PairingAdvanced Malignant NeoplasmFc DomainEngineering
Grant awards (6)
Armed Replicating Ad for Breast Cancer Bone Metastasis$225,695
R01 · FY2008 · CA · contact PI
Armed Replicating Ad for Breast Cancer Bone Metastasis$225,695
R01 · FY2007 · CA · contact PI
Armed Replicating Ad for Breast Cancer Bone Metastasis$232,436
R01 · FY2006 · CA · contact PI
A NOVEL STRATEGY FOR OSTEOPOROSIS GENE THERAPY$71,750
R03 · FY2003 · AR
A NOVEL STRATEGY FOR OSTEOPOROSIS GENE THERAPY$71,750
R03 · FY2002 · AR
A NOVEL STRATEGY FOR OSTEOPOROSIS GENE THERAPY$71,750
R03 · FY2001 · AR